日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Rhizobium sp. Probable farnesyl diphosphate synthase (NGR_a02750) CSB-YP346643RKX
CSB-EP346643RKX
CSB-BP346643RKX
CSB-MP346643RKX
CSB-EP346643RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4lG (NGR_a02680) CSB-YP346644RKX
CSB-EP346644RKX
CSB-BP346644RKX
CSB-MP346644RKX
CSB-EP346644RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4lL (NGR_a02630), partial CSB-YP346645RKX
CSB-EP346645RKX
CSB-BP346645RKX
CSB-MP346645RKX
CSB-EP346645RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Putative kinase Y4mE (NGR_a02540) CSB-YP346646RKX
CSB-EP346646RKX
CSB-BP346646RKX
CSB-MP346646RKX
CSB-EP346646RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4mM (NGR_a02460), partial CSB-YP346647RKX1
CSB-EP346647RKX1
CSB-BP346647RKX1
CSB-MP346647RKX1
CSB-EP346647RKX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4nG (NGR_a02350) CSB-YP346648RKX
CSB-EP346648RKX
CSB-BP346648RKX
CSB-MP346648RKX
CSB-EP346648RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4nL (NGR_a02300) CSB-YP346649RKX
CSB-EP346649RKX
CSB-BP346649RKX
CSB-MP346649RKX
CSB-EP346649RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4oN (NGR_a02210) CSB-YP346650RKX
CSB-EP346650RKX
CSB-BP346650RKX
CSB-MP346650RKX
CSB-EP346650RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized ABC transporter ATP-binding protein y4oS (NGR_a02170) CSB-YP346651RKX
CSB-EP346651RKX
CSB-BP346651RKX
CSB-MP346651RKX
CSB-EP346651RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Probable trehalose-phosphate phosphatase (otsB) CSB-YP346652RKX
CSB-EP346652RKX
CSB-BP346652RKX
CSB-MP346652RKX
CSB-EP346652RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Putative transposase y4pF/y4sB (NGR_a02060) CSB-YP346653RKX
CSB-EP346653RKX
CSB-BP346653RKX
CSB-MP346653RKX
CSB-EP346653RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. HTH-type transcriptional regulator syrM 1 (syrM1) CSB-YP346654RKX
CSB-EP346654RKX
CSB-BP346654RKX
CSB-MP346654RKX
CSB-EP346654RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized aminotransferase y4qG (NGR_a01910) CSB-YP346655RKX
CSB-EP346655RKX
CSB-BP346655RKX
CSB-MP346655RKX
CSB-EP346655RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Putative integrase/recombinase y4rE (NGR_a01820) CSB-YP346656RKX
CSB-EP346656RKX
CSB-BP346656RKX
CSB-MP346656RKX
CSB-EP346656RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized MFS-type transporter y4rN (NGR_a01730), partial CSB-YP346657RKX
CSB-EP346657RKX
CSB-BP346657RKX
CSB-MP346657RKX
CSB-EP346657RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Probable amino-acid ABC transporter periplasmic-binding protein y4tE (NGR_a01540) CSB-YP346658RKX
CSB-EP346658RKX
CSB-BP346658RKX
CSB-MP346658RKX
CSB-EP346658RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized hydrolase/peptidase y4tL (NGR_a01470) CSB-YP346659RKX
CSB-EP346659RKX
CSB-BP346659RKX
CSB-MP346659RKX
CSB-EP346659RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Uncharacterized protein y4uG (NGR_a01330), partial CSB-YP346660RKX1
CSB-EP346660RKX1
CSB-BP346660RKX1
CSB-MP346660RKX1
CSB-EP346660RKX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Protein nifX (nifX) CSB-YP346661RKX
CSB-EP346661RKX
CSB-BP346661RKX
CSB-MP346661RKX
CSB-EP346661RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium sp. Histidinol-phosphate aminotransferase (hisC) CSB-YP346662RKX
CSB-EP346662RKX
CSB-BP346662RKX
CSB-MP346662RKX
CSB-EP346662RKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×